Novartis AG
NVSEF | OTC
$138.25
+$4.55 (+3.40%)
At close: Sep 21, 2026, 3:47 PM ET
$138.25
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
+3.40%
(1D)Rating
Updated: Sep 17, 2026Key Statistics
Market Data
Market Cap $262.78B
1D Range
138.25 140.63
52W Range
118.02 171.29
Valuation (TTM)
PE 20.15
PB 6.26
EV/EBITDA 12.70
Valuation (NTM)
Forward PE 13.68
Forward PEG 1.85
Price Target N/A
Cash Flow
FCF Yield 6.9%
SBC Adj. FCF Yield 6.5%
SBC Impact -5.9%
Margins
Gross Margin 74.3%
Operating Margin 30.2%
FCF Margin 32.7%
Growth (CAGR)
Revenue 3Y | 5Y 1.5% |
2.2%
Dil EPS 3Y | 5Y -12.4% |
16.9%
FCF 3Y | 5Y 17.0% |
7.7%
Returns
ROA 10.3%
ROE 29.6%
ROIC 13.4%
Financial Health
Net Debt
$23.78B
Current Ratio 0.86
Interest Coverage 11.88
Dividends
Div Yield 3.43%
Payout Ratio 69.1%
FCF Payout Ratio 42.9%
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
2 months ago · seekingalpha.com
How To Build A $50,000 Dividend Portfolio In Today's MarketThe Dividend Income Accelerator Portfolio emphasizes high-quality companies with sustainable dividends, strong balance sheets, and attractive valuations to optimize risk-adjusted returns. I prioritize a diversified mix of ETFs and individual stocks across sectors, balancing dividend income, growth, and capital appreciation while mitigating downside risk. Key metrics include a 3.75% weighted average dividend yield, low payout ratios, and low beta factors, supporting long-term portfolio resilience.
Add to Watchlist
Select watchlists to add or remove NVSEF